Episode

Ep200: Richard Pops Reflects on a 35-Year Career in Biotech

Podcast: The Long Run with Luke Timmerman
Published: May 5, 2026
Duration seconds: 4411
Processing state: not_requested
Canonical source: https://soundcloud.com/longrunpodcast/ep200-richard-pops-on-orexin
Audio: https://feeds.soundcloud.com/stream/2315061191-longrunpodcast-ep200-richard-pops-on-orexin.mp3
JSON: /v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep200-richard-pops-reflects-on-a-35-year-career-in-biotech
Markdown: /podcast/the-long-run-with-luke-timmerman-1124799/ep200-richard-pops-reflects-on-a-35-year-career-in-biotech.md

Actions

POST https://stenobird.com/v1/public/podcasts/the-long-run-with-luke-timmerman-1124799/episodes/ep200-richard-pops-reflects-on-a-35-year-career-in-biotech/transcription-requests
Idempotently request low-priority transcript generation for this episode.
GET https://stenobird.com/podcast/the-long-run-with-luke-timmerman-1124799/ep200-richard-pops-reflects-on-a-35-year-career-in-biotech.md
Read the agent-friendly Markdown representation of this episode resource.

Summary

Alkermes CEO Richard Pops reflects on his 35-year career leading the company and its new opportunity in orexin biology for sleep disorders and more neurological conditions.